Fabry Disease: A Disorder of Childhood Onset

作者: Raphael Schiffmann , Markus Ries

DOI: 10.1016/J.PEDIATRNEUROL.2016.07.001

关键词: DiseasePathologyPediatricsPopulationEnzyme replacement therapyMedicineHeart diseaseOverdiagnosisFabry diseaseKidney diseaseAngiokeratoma

摘要: Abstract Background Fabry disease, an X-linked disorder of glycosphingolipids, markedly increases the risk systemic vasculopathy, ischemic stroke, small-fiber peripheral neuropathy, cardiac dysfunction, and chronic kidney disease. Methods We performed extensive PubMed search on topic disease drew from our cumulative 43 years experience. Results Most these complications are nonspecific in nature clinically indistinguishable similar abnormalities that occur context more common disorders general population. This is caused by variants GLA gene, its incidence may have been underestimated. However, one must also guard against overdiagnosis unjustified enzyme replacement therapy, because some gene benign. Specific therapy for has developed last few years, but clinical effect modest. Novel therapeutic agents being developed. Standard "nonspecific" medical surgical necessary effective slowing deterioration or compensating organ failure patients with Conclusions a treatable modifiable genetic factor myriad complications. be frequently overlooked occasion overdiagnosed.

参考文章(139)
Susana Ferreira, Carlos Reguenga, João Paulo Oliveira, The Modulatory Effects of the Polymorphisms in GLA 5′-Untranslated Region Upon Gene Expression Are Cell-Type Specific JIMD reports. ,vol. 23, pp. 27- 34 ,(2015) , 10.1007/8904_2015_424
Markus Niemann, Sebastian Herrmann, Kai Hu, Frank Breunig, Jörg Strotmann, Meinrad Beer, Wolfram Machann, Wolfram Voelker, Georg Ertl, Christoph Wanner, Frank Weidemann, Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment. Jacc-cardiovascular Imaging. ,vol. 4, pp. 592- 601 ,(2011) , 10.1016/J.JCMG.2011.01.020
M. Ries, E. Mengel, G. Kutschke, K. S. Kim, F. Birklein, F. Krummenauer, M. Beck, Use of gabapentin to reduce chronic neuropathic pain in Fabry disease. Journal of Inherited Metabolic Disease. ,vol. 26, pp. 413- 414 ,(2003) , 10.1023/A:1025127723729
R. A. C. Graham-Brown, S. George, Angiokeratoma corporis diffusum in fucosidosis. Journal of the Royal Society of Medicine. ,vol. 87, pp. 707- 707 ,(1994)
George R. Von Gemmingen, Ruth Sanger, John M. Opitz, R. R. Race, E. G. Cross, W. P. De Groot, Frank C. Stiles, Robert R. Kierland, David Wise, The Genetics of Angiokeratoma Corporis Diffusum (Fabry's Disease) and Its Linkage Relations with the Xg Locus. American Journal of Human Genetics. ,vol. 17, pp. 325- ,(1965)
Cristina Chimenti, Fernanda Scopelliti, Elisabetta Vulpis, Marco Tafani, Lidia Villanova, Romina Verardo, Ruggero De Paulis, Matteo A. Russo, Andrea Frustaci, Increased oxidative stress contributes to cardiomyocyte dysfunction and death in patients with Fabry disease cardiomyopathy Human Pathology. ,vol. 46, pp. 1760- 1768 ,(2015) , 10.1016/J.HUMPATH.2015.07.017
Saskia M. Rombach, Bouwien E. Smid, Gabor E. Linthorst, Marcel G. W. Dijkgraaf, Carla E. M. Hollak, Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis Journal of Inherited Metabolic Disease. ,vol. 37, pp. 341- 352 ,(2014) , 10.1007/S10545-014-9677-8
Björn Hoffmann, Satish Keshav, Gastrointestinal symptoms in Fabry disease: everything is possible, including treatment. Acta Paediatrica. ,vol. 96, pp. 84- 86 ,(2007) , 10.1111/J.1651-2227.2007.00216.X
Phillip A. Low, Tonette L. Opfer-Gehrking, The autonomic laboratory. American Journal of Electroneurodiagnostic Technology. ,vol. 39, pp. 65- 76 ,(1999) , 10.1080/1086508X.1999.11079251